Belka C - Search Results

1

Offline and online LSTM networks for respiratory motion prediction in MR-guided radiotherapy.

Lombardo E, Rabe M, Xiong Y, Nierer L, Cusumano D, Placidi L, Boldrini L, Corradini S, Niyazi M, Belka C, Riboldi M, Kurz C, Landry G. Lombardo E, et al. Among authors: belka c. Phys Med Biol. 2022 Apr 19;67(9). doi: 10.1088/1361-6560/ac60b7. Phys Med Biol. 2022. PMID: 35325880

2

Isobologram analysis of triple therapies.

Niyazi M, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2006 Oct 17;1:39. doi: 10.1186/1748-717X-1-39. Radiat Oncol. 2006. PMID: 17044920 Free PMC article.

3

Counting colonies of clonogenic assays by using densitometric software.

Niyazi M, Niyazi I, Belka C. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2007 Jan 9;2:4. doi: 10.1186/1748-717X-2-4. Radiat Oncol. 2007. PMID: 17212832 Free PMC article.

4

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Strahlenther Onkol. 2009 Jan;185(1):8-18. doi: 10.1007/s00066-009-1856-4. Epub 2009 Feb 18. Strahlenther Onkol. 2009. PMID: 19224142

5

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Oncol Rep. 2009 Jun;21(6):1455-60. doi: 10.3892/or_00000374. Oncol Rep. 2009. PMID: 19424623

6

Combination of the pro-apoptotic TRAIL-receptor antibody mapatumumab with ionizing radiation strongly increases long-term tumor control under ambient and hypoxic conditions.

Marini P, Budach W, Niyazi M, Junginger D, Stickl S, Jendrossek V, Belka C. Marini P, et al. Among authors: belka c. Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):198-202. doi: 10.1016/j.ijrobp.2009.04.038. Int J Radiat Oncol Biol Phys. 2009. PMID: 19695436

7

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions.

Marini P, Junginger D, Stickl S, Budach W, Niyazi M, Belka C. Marini P, et al. Among authors: belka c. Radiat Oncol. 2009 Oct 27;4:49. doi: 10.1186/1748-717X-4-49. Radiat Oncol. 2009. PMID: 19860913 Free PMC article.

8

Choline PET based dose-painting in prostate cancer--modelling of dose effects.

Niyazi M, Bartenstein P, Belka C, Ganswindt U. Niyazi M, et al. Among authors: belka c. Radiat Oncol. 2010 Mar 18;5:23. doi: 10.1186/1748-717X-5-23. Radiat Oncol. 2010. PMID: 20298546 Free PMC article.

9

Intensity-modulated radiotherapy for a rendu-osler-weber disease patient with recurrent severe epistaxis: a case report.

Niyazi M, Caversaccio MD, Dubach P, Geretschläger A, Arnold A, Belka C, Aebersold DM, Blumstein NM. Niyazi M, et al. Among authors: belka c. Case Rep Med. 2010;2010:321835. doi: 10.1155/2010/321835. Epub 2010 Mar 28. Case Rep Med. 2010. PMID: 20368796 Free PMC article.

10

Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C. Wolf M, et al. Among authors: belka c. Strahlenther Onkol. 2010 Jul;186(7):374-81. doi: 10.1007/s00066-010-2137-y. Epub 2010 Jun 24. Strahlenther Onkol. 2010. PMID: 20582393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters